Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer - Munster, P N; Moore, A P; Ismail-Khan, R (J Clin Oncol, 2012)
et al.